A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia

Completed · Phase 2

Conditions studied: Schizophrenia

In brief

A 1-year outpatient study to test the safety and tolerability of a new medication in the treatment of schizophrenia

Key facts

Study ID
NCT00088621
Run by
Sumitomo Pharma America, Inc.
People needed
61
Starts
2004-07-01
Expected to finish
2005-10-01
Last updated by the study team
2014-04-17

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.